Expiring federal contract
75N92026P00029 — Medunik USA INC
Department of Health and Human Services · National Institutes of Health
- Contract / PIID
- 75N92026P00029
- Incumbent
- Medunik USA INC
- Incumbent UEI
- DND9H4EQ14T5
- Current end date
- December 31, 2026
- Potential total value
- $210,000
- Obligated
- $210,000
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- Set-aside
- Full & Open
- Start date
- December 19, 2025
- Place of performance
- NJ
- Award type
- PURCHASE ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
MEDICATION - PHENBURANE
Likely rebid window (estimate)
- Sources Sought / RFI: about Dec 2025 – Jun 2026 (6–12 months before the end date)
- RFP: about Aug 2026 – Oct 2026 (2–4 months before the end date)
In the final months before the current end date.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325412)
- 75H71226F80004 — Mckesson Corporation · ends November 25, 2026 · $114K
- 75H71224P00137 — Four Points Technology, L.L.C. · ends November 30, 2026 · $240K
- 75H71226F80005 — Mckesson Corporation · ends December 21, 2026 · $1.6M
- 75H71026P00562 — Mckesson Corporation · ends December 31, 2026 · $131K
- 75N93024P01131 — United Biopharma, INC. · ends December 31, 2026 · $400K
- 75A50120C00092 — Phlow Corp. · ends January 13, 2027 · $697M
- 75D30123C17978 — Mckesson Specialty Distribution LLC · ends January 31, 2027 · $204M
- 75N95019F00088 — Mriglobal · ends January 31, 2027 · $2.4M
- 75N90024F00080 — Ino Therapeutics LLC · ends February 28, 2027 · $115K
- 75H71126F80051 — Sanofi Vaccines US INC. · ends March 14, 2027 · $2.0M